AI assistant
Sending…
MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2011
Apr 18, 2011
30608_dirs_2011-04-18_819edee8-7271-4477-97db-ae54f3a78c28.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYNTA PHARMACEUTICALS CORP (SNTA)
CIK: 0001157601
Period of Report: 2011-04-14
Reporting Person: WILSON ROBERT N (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-04-14 | Common Stock | P | 50000 | $4.89 | Acquired | 522399 | Direct |
More from MADRIGAL PHARMACEUTICALS, INC.
Interim / Quarterly Report
2026
May 6
Earnings Release
2026
May 6
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 24
Annual Report
2026
Feb 19
Earnings Release
2026
Feb 19
Regulatory Filings
2026
Jan 30
Director's Dealing
2026
Jan 26